Form 4: WBA Director Receives Annual Equity Compensation
Insider Transaction Report
Walgreens Boots Alliance director Thomas E. Polen Jr. received annual compensation in common stock and phantom stock units.
Summary
- Thomas E. Polen Jr., a Director of Walgreens Boots Alliance, Inc. (WBA), acquired 11,774 shares of common stock.
- The common stock was granted as annual non-employee director compensation under the company's 2021 Omnibus Incentive Plan, with a transaction price of $0 per share.
- Polen also acquired 5,046.26 phantom stock units, also as annual non-employee director compensation, valued at $11.89 per unit.
- Each phantom stock unit is the economic equivalent of one share of the company's common stock.
- The phantom stock units are to be settled following the termination of service as a director.
- Following these transactions, Polen beneficially owns 28,269 shares of common stock and 12,356.58 phantom stock units.
- The phantom stock units balance includes units issued in lieu of dividends on outstanding phantom stock units.
Sentiment
Score: 5
Explanation: The filing is neutral as it reports a routine, pre-scheduled compensation event for a director, which is a standard operational disclosure and does not indicate any significant positive or negative operational or financial news.
Positives
- The grant of equity compensation aligns the interests of the non-employee director with those of shareholders.
- The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned and transparent transaction.
Future Outlook
The phantom stock units are to be settled following the termination of service as a director in accordance with the terms and conditions of the Plan.
Industry Context
This filing represents a routine compensation disclosure for a non-employee director, common practice across publicly traded companies to incentivize and retain board members through equity-based awards.
Comparison to Industry Standards
- The use of both common stock grants and phantom stock units for director compensation is a standard practice in large public companies, aligning director interests with long-term shareholder value.
- The grant under an Omnibus Incentive Plan is typical for broad-based equity compensation programs, similar to those at peer companies in the retail pharmacy and healthcare sectors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Utilization | Annual share grant and phantom stock unit grant issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan. | 08/13/2025 | Reinforces the company's established equity compensation framework for non-employee directors, aligning their interests with long-term company performance. |
Related Party Transactions
- The acquisition of common stock and phantom stock units by Thomas E. Polen Jr., a director, constitutes compensation from the company, which is a related party transaction.
Stakeholder Impact
- Shareholders: The grant of equity compensation to a director is a standard practice intended to align director interests with shareholder value, though it results in minor dilution over time.
- Employees: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 08/13/2025 | Date of transaction for common stock and phantom stock unit acquisition. |
| 08/15/2025 | Date the Form 4 was signed and filed. |
Keywords
Walgreens Boots Alliance, WBA, SEC Form 4, Director Compensation, Equity Grant, Phantom Stock Units, Insider Transaction, Executive Compensation, Omnibus Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.